Biosimilar Insulin In The Management Of Diabetes In Patients

Speciality: Endocrinology


Speaker:

Dr. Shehla Shaikh | DM (ENDOCRINOLOGY), MD (GENERAL MEDICINE)

Dr. Sujoy Ghosh | MBBS, MD, DM(ENDOCRINOLOGY), MRCP(UK), FRCP(LONDON, GLASGOW, EDINBURGH)

Description:

A warm welcome to all the medical practitioners in this interesting session of biosimilar insulin.

Insulin is a hormone secreted from pancreas that helps blood sugar to enter the body's cells so it can be used for energy. Insulin also signals the liver to store blood sugar for later use. It is one of the important components that helps in controlling diabetes in patients.

The speakers Dr. Shehla Shaikh, Dr. Sujoy Ghosh, and panel has provided an elaborative knowledge on biosimilar insulin in the management of diabetes in patients. 

Biosimilar insulins are manufactured in living organisms (e.g., yeast and bacteria) to produce large quantities of the product, which limits the ability to manufacture exact replicas of original biological medications. The manufacture and use of biosimilar insulin will be much cost effective and can be used in lower or middle income countries. 

Therefore, listen to the webinar, grab the knowledge that is shared and follow HiDoc for more such interesting webinar sessions.
 



See More Webinars @ Hidoc Webinars




Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

A single-cell analysis reveals a distinctive immunosuppressive tumor microenvironment in kidney cancer brain metastases.

2.

The FDA approves Enhertu for HER2-positive cancers, regardless of tumor type.

3.

Cancer diagnosis does not spur improvements to survivors' diets or eating habits

4.

According to a study by Amrita Hospital in Kochi, cancer mortality is rising among Indian women while declining for men.

5.

A garden can save your life


© Copyright 2025 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
bot